Related Questions

Tumours that can be identified by tumour markers include
A Choriocarcinoma
B Seminoma
C Endometrial carcinoma
D Carcinoma cervix
E Ameloblastoma
Tumour markers used for screening
A Calcitonin for medullary carcinoma of thyroid
B -fetoprotein for hepatocellular carcinoma
C Neuron-specific enolase for small cell carcinoma
D CA – 125 for breast cancer
E CA – 19- 9 for ovarian cancer
Followings are considered as tumour markers for testicular tumor
A α-fetoprotein
B Lactate dehydrogenase
C β-HCG
D CA-19-9
E CA-125
Malignant tumour/s of bone is/are
A Ewing's sarcoma
B Multiple myeloma
C Osteoclastoma
D Giant cell tumour
E Fibrous dysplasia
Malignant tumour/s of stomach
A Adenosquamous carcinoma
B Leiomyosarcoma
C Lymphoma
D Rhabdomyosrcoma
E Haemangioma
Regarding differentiation and anaplasia of a tumour
A Are assessed under microscope
B Malignant tumours are never well differentiated
C Benign tumours may show features of anaplasia
D Staging is dependent on the above factors [Robbins/332]
E Are subjective assessment
Tumour/s that commonly metastasize to the bone
A Carcinoma of prostate
B Renal cell carcinoma
C Carcinoma of breast
D Choriocarcinoma of placenta
E Adenocarcinoma of gall bladder
Hormone dependent tumour(s) is/are
A Carcinoma breast
B Carcinoma prostate
C Endometrial carcinoma
D Medullary carcinoma of thyroid
E Renal cell carcinoma
Hormone producing tumour/s of ovary
A Granulosa cell tumour
B Struma ovary
C Brenner tumour
D Dysgerminoma
E Choriocarcinoma
Hormone dependent tumour are
A Carcinoma of breast
B Carcinoma of prostate
C Endometrial carcinoma
D Papillary thyroid carcinoma
E Pituitary adenoma

Next steps